Prospective Cohort With Hemopathy in Languedoc-Roussillon
NCT02134574 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2022-01-04
Summary
Prospective Cohort Study of clinical and laboratory data of patients with hemopathy.
Conditions
- Hematologic Malignancy
Interventions
- BIOLOGICAL
-
hematologic malignancy
hematologic malignancy with a sampling of blood
Sponsors & Collaborators
-
University Hospital, Montpellier
lead OTHER
Principal Investigators
-
GUILLAUME CARTRON · University Hospital, Montpellier
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-02-28
- Primary Completion
- 2033-06-30
- Completion
- 2033-06-30
Countries
- France
Study Locations
More Related Trials
-
18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy
NCT03741231 ·Status: COMPLETED
-
Assessment of [18F]FLT-PET Imaging for Diagnosis and Prognosis of Brain Tumors
NCT00850278 ·Status: COMPLETED ·Phase: NA
-
Creation of a Normal Database for FluoroDeoxyGlucose-Positron Emission Tomography (FDG-PET) Neurological Examinations
NCT02858167 ·Status: COMPLETED ·Phase: NA
-
Relevance of [68Ga]Ga -PentixaFor-PET for Initial Staging and Therapeutic Evaluation of Multiple Myeloma
NCT04561492 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation of PET 18F-Fludarabine for the Initial Assessment and End-treatment of Symptomatic Multiple Myeloma Patients
NCT03832127 ·Status: RECRUITING ·Phase: PHASE1
-
The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern Italy
NCT01248000 ·Status: COMPLETED
-
PET-based Evaluation of Chemotherapy-induced Brain Damage in Lymphoma
NCT02601547 ·Status: COMPLETED ·Phase: NA
-
Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin
NCT02856347 ·Status: COMPLETED ·Phase: NA
-
Benefits Study of Respiratory-gated PET Acquisition in Lung Disease
NCT01812031 ·Status: COMPLETED ·Phase: NA
-
The Value of Preoperative Sentinel Lymph Node Mapping by Pelvic MR Lymphangiography and SPECT-CT in Cervical Cancer
NCT01777230 ·Status: WITHDRAWN
-
Repeatability of Positron Emission Tomography (TEP) With fluorométhyl-(18F)-diméthyl-2-hydroxyéthyl-ammonium
NCT03105869 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder Cancer
NCT01655745 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma
NCT04566185 ·Status: COMPLETED ·Phase: NA
-
IL-2 PET Imaging in Advanced Solid Tumours
NCT05471271 ·Status: TERMINATED ·Phase: NA
-
PET-CT in Lymphoma Among the Eldery
NCT07259941 ·Status: NOT_YET_RECRUITING
-
Interim FDG PET-CT in Melanoma Metastatic Patient's Treated by Anti-PD1 Therapy
NCT03888950 ·Status: RECRUITING ·Phase: NA
-
Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers
NCT01421953 ·Status: COMPLETED ·Phase: NA
-
PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents
NCT02325349 ·Status: TERMINATED ·Phase: PHASE2
-
Interest of a Systematic One-year Monitoring by 18F-FDG PET-CT
NCT04464590 ·Status: COMPLETED
-
Elevated LDH Serum Levels and FDG-PET in Metastatic Melanoma Patients
NCT02949154 ·Status: COMPLETED
-
Sentinel Lymph Node Mapping Using Magtrace and MRI in Healthy Subjects for Potential Use in Melanoma Patients
NCT05054062 ·Status: COMPLETED ·Phase: NA
-
Choline PET/CT vs. Dual Time Point FDG PET/CT in Prostate Cancer
NCT02232724 ·Status: COMPLETED ·Phase: NA
-
Study of the Angiogenesis by PET/CT in Patients With Lymphoma
NCT02490891 ·Status: COMPLETED ·Phase: PHASE2
-
FAPI PET/CT for Lymph Node Staging in Colorectal Carcinoma
NCT05209750 ·Status: UNKNOWN ·Phase: NA
-
FLT PET/MR for Evaluation of Pseudoprogression in Patients With Brain Lesions
NCT02328300 ·Status: WITHDRAWN